CD274 and breast cancer: PD-L1 on MC38 colorectal adenocarcinoma cells and 4T1 breast cancer cells is sufficient to suppress antitumor immunity through tumor immune evasion or correlates with an inflamed tumor microenvironment and inhibits CD8 T-cell cytotoxicity.